Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 16, 2018 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce Second Quarter 2018 Financial Results on Monday August 6, 2018

TEMPLE CITY, Calif., July 16, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its second quarter 2018...
May 07, 2018 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Reports First Quarter 2018 Financial Results

First Quarter 2018 Results: Revenue of $4.7 million, up 9% sequentiallyBillable tests delivered grew 10% sequentially to 4,621GAAP loss of $1.9 million, or $0.11 per shareNon-GAAP loss of $1.2...
April 23, 2018 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce First Quarter 2018 Financial Results on Monday May 7, 2018

TEMPLE CITY, Calif., April 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its first quarter 2018...
February 28, 2018 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Reports Fourth Quarter and Full Year 2017 Financial Results

Fourth Quarter of 2017 Results: Revenue of $4.3 millionGAAP loss of $1.8 million, or $0.10 per shareNon-GAAP loss of $1.0 million, or $0.06 per shareAdjusted EBITDA loss of $952,000 Full Year 2017...
February 23, 2018 08:00 ET | Source: Fulgent Genetics, Inc.

Representatives of Fulgent Genetics to Participate in 2018 BTIG Healthcare Conference

TEMPLE CITY, Calif., Feb. 23, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
February 13, 2018 08:00 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce Fourth Quarter and Full Year 2017 Financial Results on February 28, 2018

TEMPLE CITY, Calif., Feb. 13, 2018 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its fourth quarter and full...
November 14, 2017 08:30 ET | Source: Fulgent Genetics, Inc.

Representatives of Fulgent Genetics to Participate in the Piper Jaffray 29th Annual Healthcare Conference

TEMPLE CITY, Calif., Nov. 14, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
November 06, 2017 16:05 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics Reports Third Quarter 2017 Financial Results

Revenue of $4.5 MillionGAAP Loss of $1.1 million, or $0.06 per ShareNon-GAAP loss of $442,000, or $0.02 per ShareAdjusted EBITDA loss of $458,000 TEMPLE CITY, Calif., Nov. 06, 2017 (GLOBE NEWSWIRE)...
October 24, 2017 08:30 ET | Source: Fulgent Genetics, Inc.

Representatives of Fulgent Genetics to Participate in the Credit Suisse 26th Annual Healthcare Conference

TEMPLE CITY, Calif., Oct. 24, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that its Chairman and Chief Executive Officer Ming...
October 23, 2017 08:30 ET | Source: Fulgent Genetics, Inc.

Fulgent Genetics to Announce Third Quarter 2017 Financial Results on November 6, 2017

TEMPLE CITY, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ:FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2017...